Misoprostol for postpartum hemorrhage

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 17 Feb 2022: Trial registered, NCT05245227
  2. 27 Jan 2025: Trial started, NCT05245227

The trials

NCT05245227: Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage

State
Under way
Phase
Phase 3
People
1,358 planned
Started
27 Jan 2025
Primary completion
1 Jan 2027
Arms
Misoprostol plus intravenous Oxytocin
Results
None posted
  1. 17 Feb 2022: Trial registered
  2. 27 Jan 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Also known as Arthrotec component misoprostol, Cytotec.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.